Clinical relevance of hyper-recombination in cancer


Dr. Anand Jeyasekharan, Consultant, Department of Haematology-Oncology, National University Hospital Singapore, and PI at the Cancer Science Institute, National University of Singapore

Date & Time:

Monday, 7 October 2019, 14:00

Old Road Campus Research Building, Ludwig seminar room, basement of ORCRB, Headington OX3 7DQ
Department of Oncology
About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.